Thermal and in Situ X-ray Diffraction Analysis of a Dimorphic Co-Crystal, 1:1 Caffeine-Glutaric Acid

被引:24
作者
Vangala, Venu R. [1 ,3 ]
Chow, Pui Shan [1 ]
Schreyer, Martin [1 ]
Lau, Grace [1 ]
Tan, Reginald B. H. [1 ,2 ]
机构
[1] ASTAR, Inst Chem & Engn Sci, Crystallisat & Particle Sci, 1 Pesek Rd, Singapore 627833, Singapore
[2] Natl Univ Singapore 4, Dept Chem & Biomol Engn, Engn Dr 4, Singapore 117576, Singapore
[3] Univ Bradford, Ctr Pharmaceut Engn Sci, Sch Pharm, Bradford BD7 1DP, W Yorkshire, England
关键词
POLYMORPHISM; COCRYSTAL; KINETICS; MECHANOCHEMISTRY; MECHANISM; SOLVENT; DRUG;
D O I
10.1021/acs.cgd.5b00798
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Spurred by the enormous interest in co-crystals from the pharmaceutical industry, many novel co-crystals of active pharmaceutical ingredients have been discovered in recent years, and this has in turn led to an increasing number of reports on polymorphs of co-crystals. Hence, a thorough characterization and understanding of co-crystal polymorphs is a valuable step during drug development. The purpose of this study is to perform in situ structural analysis and to determine thermodynamic stability of a dimorphic co-crystal system, 1:1 caffeine glutaric acid (CA-GA, Forms I and II). We performed thermal and structural characterizations by differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), hot-stage microscopy (HSM), and slurry and in situ variable temperature X-ray diffraction (VTXRD). For completeness, we have also redetermined crystal structures of CA GA Forms I and II at 180 K using single crystal X-ray diffraction. Our results revealed that Form II is stable and Form I is metastable at ambient conditions. Further, the results suggest that the dimorphs are enantiotropically related and the transition temperature is estimated to be 79 degrees C.
引用
收藏
页码:578 / 586
页数:9
相关论文
共 36 条
[1]   Trimorphs of a pharmaceutical cocrystal involving two active pharmaceutical ingredients: potential relevance to combination drugs [J].
Aitipamula, Srinivasulu ;
Chow, Pui Shan ;
Tan, Reginald B. H. .
CRYSTENGCOMM, 2009, 11 (09) :1823-1827
[2]   Polymorphism in cocrystals: a review and assessment of its significance [J].
Aitipamula, Srinivasulu ;
Chow, Pui Shan ;
Tan, Reginald B. H. .
CRYSTENGCOMM, 2014, 16 (17) :3451-3465
[3]  
Bernstein J., 2020, Polymorphism in molecular crystals 2e, Vvol. 30
[4]   Celecoxib cocrystal polymorphs with cyclic amides: synthons of a sulfonamide drug with carboxamide coformers [J].
Bolla, Geetha ;
Mittapalli, Sudhir ;
Nangia, Ashwini .
CRYSTENGCOMM, 2014, 16 (01) :24-27
[5]   Three Polymorphic Forms of the Co-Crystal 4,4′-Bipyridine/Pimelic Acid and their Structural, Thermal, and Spectroscopic Characterization [J].
Braga, Dario ;
Palladino, Giuseppe ;
Polito, Marco ;
Rubini, Katia ;
Grepioni, Fabrizia ;
Chierotti, Michele R. ;
Gobetto, Roberto .
CHEMISTRY-A EUROPEAN JOURNAL, 2008, 14 (32) :10149-10159
[6]  
Brittain H.G., 2009, Polymorphism in pharmaceutical solids, V192
[7]  
BURGER A, 1979, MIKROCHIM ACTA, V2, P273
[8]   POLYMORPHISM OF PHARMACEUTICALS AND OTHER MOLECULAR-CRYSTALS .1. THEORY OF THERMODYNAMIC RULES [J].
BURGER, A ;
RAMBERGER, R .
MIKROCHIMICA ACTA, 1979, 2 (3-4) :259-271
[9]  
Byrn S.R., 1999, Solid State Chemistry of Drugs, VSecond
[10]   Structure-Stability Relationships in Cocrystal Hydrates: Does the Promiscuity of Water Make Crystalline Hydrates the Nemesis of Crystal Engineering? [J].
Clarke, Heather D. ;
Arora, Kapildev K. ;
Bass, Heather ;
Kavuru, Padmini ;
Ong, Tien Teng ;
Pujari, Twarita ;
Wojtas, Lukasz ;
Zaworotko, Michael J. .
CRYSTAL GROWTH & DESIGN, 2010, 10 (05) :2152-2167